Our immune cell products combine NK T CIK and tumor - killing immune cells Extracted non - invasively from donors or patients they're cultured in advanced labs These cells act as a powerful defense system targeting cancer cells and disease - causing pathogens
Product Type
Cell Culture Products
Endotoxin Level
< 1 EU/µg
Cell Type
Immune Cells
Features
Multifunctional synergy Different immune cells work together NK cells start attacks T cells offer targeted immunity CIK cells boost responses and tumor - killing cells strike cancer cells for maximum effect
Gene - editing tech use We apply CRISPR - Cas9 to enhance immune cells like modifying T cells with CARs for better cancer targeting
Sustainable cell production Our patented system ensures a steady supply of high - quality immune cells to meet growing demand
Technical Parameters
Cell viability Maintained at 99% after quality control ensuring top - condition cells for treatment
Cell purity Purified over 97% to remove contaminants and ensure treatment safety and effectiveness
Enhanced cytokine production Optimized culture conditions boost cytokine production increasing effectiveness by 50% compared to traditional methods
Applications
Refractory cancer treatment Offers hope for patients unresponsive to traditional cancer treatments often combined with other therapies
Infectious disease control Used to prevent and treat infectious diseases especially those from drug - resistant pathogens like in HIV patients
Neurodegenerative disease exploration Under research for potential in treating neurodegenerative diseases like Alzheimer's and Parkinson's by modulating brain immune responses